Filing Details
- Accession Number:
- 0001127602-19-018736
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-16 16:26:46
- Reporting Period:
- 2019-05-14
- Accepted Time:
- 2019-05-16 16:26:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 313143 | Haemonetics Corp | HAE | Surgical & Medical Instruments & Apparatus (3841) | 042882273 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1713517 | Jacqueline Scanlan | 400 Wood Road Braintree MA 02184 | Svp, Global Human Resources | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-14 | 1,299 | $38.43 | 5,745 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-05-14 | 1,508 | $100.00 | 4,237 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-05-14 | 1,530 | $0.00 | 5,990 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2019-05-14 | 1,299 | $0.00 | 1,299 | $38.43 |
| Common Stock | Non-qualified Stock Option (Right to Buy) | Acquisiton | 2019-05-14 | 5,342 | $0.00 | 5,342 | $98.03 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,599 | 2018-03-06 | 2024-03-06 | No | 4 | M | Direct |
| 5,342 | 2026-05-14 | No | 4 | A | Direct |
Footnotes
- Transaction pursuant to an existing 10b5-1 trading plan.
- This number includes unvested restricted stock units previously reported.
- The securities awarded are in the form of restricted stock units issued pursuant to the Haemonetics Corporation 2005 Long-Term Incentive Compensation Plan (as amended). The restricted stock units vest in annual increments of 25% beginning on the first anniversary of the date of grant.
- Each restricted stock unit represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
- This number includes unvested restricted stock units previously reported and 223 shares purchased by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on April 30, 2019.
- Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.
Billionaire Hedge Funds
